A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Topical ESR-114 in Subjects With Plaque Psoriasis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
This is a multicenter, double‐blind, randomized, vehicle‐controlled, parallel‐group proof‐of‐concept study designed to assess the safety, tolerability, pharmacokinetics, and preliminary efficacy of topically applied ESR‐114 following twice daily (BID) application for 42 days (6 weeks).
Epistemonikos ID: a6f5502bc558fb767b3f6a2c26ebaae22c0990c5
First added on: May 21, 2024